• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Orchid Chemicals completes business transfer to Hospira

      Posted AtEconomictimes.indiatimes.com

      CHENNAI: City-based drug maker Orchid Chemicals & Pharmaceuticals has completed the sale and transfer of its generic injectable finished dosage business to Hospira Healthcare India Pvt Ltd, a wholly owned subsidiary of Hospira Inc, US.

      Orchid Chemicals had signed a business transfer agreement with Hospira last December to sell its injectibles business, the manufacturing complex, research and development facility at Irungattukottai near here along with employees for $400 million.

      Hospira, which has a 50:50 joint venture with the Ahmedabad-based Zydus Cadilla to manufacture oncological drugs, found the Orchid plant an apt fit as it did not have a presence in that segment.

      What further attracted the US company is the regulatory approvals -- including one from USFDA (US Food and Drug Administration) -- Orchid had.

      Orchid Managing Director K Raghavendra Rao said Tuesday the completion of the deal would enable the company to achieve financial flexibililty.

      "In addition, through the strategic supply arrangement with Hospira, Orchid would be ensuring long-term contractual API (active pharmaceutical ingredients) revenue streams," he said.

      CB Rao, Orchid's deputy managing director, will head Hospira India as its managing director.

      April 07, 2010


      Share this Article!

    Back to top^